0.00Open0.05Pre Close0 Volume49 Open Interest70.00Strike Price0.00Turnover120.39%IV11.23%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0259Delta0.0121Gamma1576.00Leverage Ratio-0.0500Theta-0.0001Rho-40.78Eff Leverage0.0025Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet